May 18, 2018 / 3:16 PM / a year ago

WHO expects to get approval to use ZMapp Ebola drug in Congo

GENEVA (Reuters) - The World Health Organization is discussing with Democratic Republic of Congo whether the government will give approval for the use of Mapp Biopharmaceutical’s experimental ZMapp treatment for Ebola, a senior WHO official said on Friday.

“We believe it’s likely in the coming days,” WHO’s Deputy Director-General of Emergency Preparedness and Response Peter Salama told a news conference in Geneva.

Reporting by Tom Miles and Kate Kelland; Editing by Catherine Evans

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below